Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer

This study has been completed.
National Cancer Institute (NCI)
Celgene Corporation
Information provided by (Responsible Party):
Dineo Khabele, Vanderbilt University Identifier:
First received: March 30, 2010
Last updated: December 9, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2015
  Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)